Abstract:X-ray cross-complementing group 6 (XRCC6) plays an important role in the DNA double-strand breaks repair and the maintenance of genomic integrity. XRCC6 C1310G polymorphism may be involved in the development of cancer through increasing genomic damages. However, studies investigating the relationship between XRCC6 C1310G polymorphism and cancer risk yielded contradictory results. To shed some light on these inconsistent findings, a meta-analysis was performed to clarify the effect of XRCC6 C1310G polymorphism on the susceptibility of cancer. A systemic literature search of PubMed, EMBASE, and China National Knowledge Infrastructure databases was conducted from their inception to September 26, 2012. The association between XRCC6 C1310G and cancer risk was assessed by the pooled odds ratio (OR) with 95 % confidence intervals (95 % CI) calculated by meta-analysis. A total of 15 eligible studies (4,642 cancer cases and 6,059 controls) were identified. Overall, there was obvious evidence for an association between XRCC6 C1310G polymorphism and increased risk of cancer under two genetic comparisons (GG vs. CC: fixed-effect OR 1.35, 95 % CI 1.10–1.66, I 2 = 17.0 %; GG vs. CG/CC: fixed-effect OR 1.25, 95 % CI 1.02–1.53, I 2 = 0.0 %). Subgroup analysis indicated that the association was significant in Asians (G vs. C: random-effect OR 1.13, 95 % CI 1.01–1.26, I 2 = 51.3 %; GG vs. CC: fixed-effect OR 1.43, 95 % CI 1.14–1.81, I 2 = 0.0 %; GG vs. CG/CC: fixed-effect OR 1.37, 95 % CI 1.09–1.72, I 2 = 0.0 %), but not in Europeans. Data from the current meta-analysis support the existence of an association between XRCC6 C1310G polymorphism and cancer risk in Asians. Studies with larger sample size are needed to further evaluate the influence of XRCC6 C1310G polymorphism on susceptibility of various cancers.

Genetic polymorphism and risk of diseases induced by chemicals

Relationship between metabolic enzyme polymorphism and colorectal cancer.

Study on polymorphisms in metabolic enzyme genes,DNA repair genes and individual susceptibility to childhood leukemia

Polymorphisms of metabolic enzymes in relation to susceptibility of lung cancer

Progress in research of cytochrome P450 3A4 gene polymorphism

Advance in Genetic Polymorphism of Cytochrome P450 2C19

Progress in relationship of cytochrome P450 1A2 genetic polymorphism,substance metabolism and carcinogenesis

Relationship Between Polymorphisms of DNA Repair Gene ERCC1 and Susceptibility to Lung Cancer

Recent Progress in Research on Susceptibility to Arsenic Poisoning and Genetic Polymorphism

Analysis of the Relationship Between DNA Repair Gene Polymorphisms and Lung Cancer Susceptibility

Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk

Drug-Metabolizing Enzyme CYP2D6 Polymorphism and Phenotypes

Genetic Polymorphism of Cytochrome P450 and Drug Metabolism

The relationship between gene polymorphism of toxin metabolic enzyme CYP2E1 and susceptibility to chronic benzene poisoning

Pharmacogenomics on anti-cancer drugs: research advances

Genetic Polymorphism in Bladder Cancer.

Effect of CYP2E1 Polymorphism on DNA Stability and Lung Cancer Susceptibility

A Case-Control Study on the Association Between Genetic Polymorphisms of Metabolizing Enzymes CYP2D6 and Susceptibility to Lung Cancer

Research Advances on Correlation Between Polymorphism of Genetic Gene and Susceptibility to Chronic Obstructive Pulmonary Disease

Polymorphisms in Phase I and Phase II Metabolism Genes and Risk of Chronic Benzene Poisoning in a Chinese Occupational Population.

Progress of Polymorphism of XRCC1 Gene in Predicting Tumor Response to Chemotherapy and Prognosis